ALX Oncology (ALXO) Insider Trading & Ownership $1.69 -0.14 (-7.65%) (As of 04:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALX Oncology (NASDAQ:ALXO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$198,624.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.85 M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALXO Insider Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW ALX Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Rekha HemrajaniDirectorBuy30,000$1.55$46,500.00 8/14/2024Shelly PintoCAOSell564$2.58$1,455.12 8/14/2024Sophia RandolphInsiderSell1,365$2.58$3,521.70 7/11/2024Jaume PonsInsiderSell20,000$7.90$158,000.00 7/5/2024Shelly PintoCAOSell1,823$5.50$10,026.50 7/1/2024Shelly PintoCAOSell1,373$5.82$7,990.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/1/2024Sophia RandolphInsiderSell3,273$5.82$19,048.86 6/13/2024Peter S GarciaCFOBuy12,000$8.53$102,360.00 6/4/2024Jaume PonsInsiderSell20,000$8.43$168,600.00 5/13/2024Sophia RandolphInsiderSell12,000$15.94$191,280.00 5/6/2024Jaume PonsInsiderSell20,000$15.92$318,400.00 4/16/2024Jaume PonsInsiderSell50,000$14.20$710,000.00 4/4/2024Jaume PonsInsiderSell20,000$11.15$223,000.00 3/14/2024Jason LettmannCEOBuy4,400$11.31$49,764.00 1/4/2024Shelly PintoCAOSell2,717$13.60$36,951.20 (Data available from 1/1/2013 forward) ALXO Insider Trading Activity - Frequently Asked Questions Who is on ALX Oncology's Insider Roster? The list of insiders at ALX Oncology includes Jason Lettmann, Jaume Pons, Peter S Garcia, Rekha Hemrajani, Shelly Pinto, and Sophia Randolph. Learn more on insiders at ALXO. What percentage of ALX Oncology stock is owned by insiders? 33.40% of ALX Oncology stock is owned by insiders. Learn more on ALXO's insider holdings. Which ALX Oncology insiders have been buying company stock? The following insiders have purchased ALXO shares in the last 24 months: Jason Lettmann ($49,764.00), Peter S Garcia ($102,360.00), and Rekha Hemrajani ($46,500.00). How much insider buying is happening at ALX Oncology? Insiders have purchased a total of 46,400 ALXO shares in the last 24 months for a total of $198,624.00 bought. Which ALX Oncology insiders have been selling company stock? The following insiders have sold ALXO shares in the last 24 months: Jaume Pons ($1,601,546.72), Peter S Garcia ($6,510.58), Shelly Pinto ($107,733.52), and Sophia Randolph ($225,631.26). How much insider selling is happening at ALX Oncology? Insiders have sold a total of 166,626 ALX Oncology shares in the last 24 months for a total of $1,941,422.08 sold. ALX Oncology Key ExecutivesDr. Corey S. Goodman Ph.D. (Age 72)Executive Chairman Compensation: $84kMr. Jason W. Lettmann (Age 47)CEO & Director Compensation: $60.5kDr. Jaume Pons Ph.D. (Age 57)Founder, President, Director & Chief Scientific Officer Compensation: $856.29kMr. Peter S. Garcia M.B.A. (Age 62)Chief Financial Officer Compensation: $631.11kDr. Sophia Randolph M.D. (Age 56)Ph.D., Chief Medical Officer & Director Compensation: $637.24kDr. Michael Chang Ph.D.Vice President of OperationsMs. Shelly Pinto (Age 47)Senior VP of Finance & Chief Accounting Officer Compensation: $508.26k3 recent tradesDr. Christopher Byrd J.D.Ph.D., General CounselDr. Athanasios Tsiatis M.D.Senior Vice President of Clinical DevelopmentDr. Lin Yeong-Liang M.D.M.S., Senior Vice President of Drug Safety & Pharmacovigilance More Insider Trading Tools from MarketBeat Related Companies IGM Biosciences Insider Buying Cryoport Insider Buying Taysha Gene Therapies Insider Buying REGENXBIO Insider Buying Y-mAbs Therapeutics Insider Buying Sana Biotechnology Insider Buying Design Therapeutics Insider Buying Tango Therapeutics Insider Buying Sage Therapeutics Insider Buying Neurogene Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:ALXO) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredIs Jeff Bezos Crowning the Next Nvidia?It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company ...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
